HDL Benefit Drug Interactions
Currently displaying a list of 107 drugs known to interact with HDL Benefit (niacin).
- 14 major drug interactions
- 81 moderate drug interactions
- 12 minor drug interactions
Medications known to interact with HDL Benefit
Note: Showing generic names only.
A
- acarbose
- acetohexamide
- albiglutide
- alogliptin
- ashwaganda
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- aspirin
- atorvastatin
B
C
- calaspargase pegol
- canagliflozin
- cannabidiol
- carbamazepine
- cerivastatin
- chlorpropamide
- choline salicylate
- clofarabine
- clozapine
D
E
F
G
I
- idelalisib
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- interferon beta-1a
- interferon beta-1b
- isoniazid
K
L
M
N
P
R
S
- salsalate
- saxagliptin
- semaglutide
- simvastatin
- sirolimus
- sitagliptin
- sodium salicylate
- sodium thiosalicylate
- sotagliflozin
- sulfinpyrazone
T
- telbivudine
- temsirolimus
- teriflunomide
- thioguanine
- tirzepatide
- tolazamide
- tolbutamide
- trabectedin
- troglitazone
V
Z
HDL Benefit alcohol/food interactions
There are 2 alcohol/food interactions with HDL Benefit (niacin).
HDL Benefit disease interactions
There are 5 disease interactions with HDL Benefit (niacin) which include:
More about HDL Benefit (niacin)
- HDL Benefit consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antihyperlipidemic agents
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.